The 31-gene expression profile as a guide to better risk-aligned care decisions for patients with stage I–III cutaneous melanoma: An NCI-SEER analysis. Hazard ratios for subsequent MCC clinical ...
Jane Tiller receives funding through an Investigator Grant from the National Health and Medical Research Council. She is co-lead of the DNA Screen study, which was funded through the Australian ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...